markets

VolitionRx Reports Q3 2026 Financial Results and Business Update

Summarized from All Financial Services & Investing

VolitionRx Limited released its third-quarter 2026 financial results, with a conference call set for Nov. 13 to discuss performance.

VolitionRx Reports Q3 2026 Financial Results and Business Update

VolitionRx Limited, a multinational epigenetics company trading on NYSE American under the ticker VNRX, released its third-quarter 2026 financial results on Wednesday, Nov. 12, according to a company announcement issued from Henderson, Nevada.

The Henderson-based firm scheduled a conference call for Friday, Nov. 13 at 8:30 a.m. Eastern Time to walk investors and analysts through the financial and operational details of the quarter. Such calls typically allow management to address key metrics, strategic developments, and forward-looking priorities directly with stakeholders.

Read more Leverage Shares Launches 2x Long Anthropic ETF as ANT Debuts on Nasdaq →

VolitionRx describes itself as a multinational epigenetics company, a field focused on the study of heritable changes in gene expression that do not involve alterations to the underlying DNA sequence. Epigenetics-based diagnostics have drawn growing interest from investors and researchers as potential tools for early disease detection and personalized medicine, positioning companies in this space at the intersection of biotechnology and clinical diagnostics.

The announcement follows a broader period of investor focus on small-cap biotech firms listed on junior exchanges such as NYSE American, where companies like VolitionRx often face heightened scrutiny over cash runway, clinical progress, and revenue milestones. The company's quarterly update is expected to shed light on where it stands against those benchmarks.

Continue reading at All Financial Services & Investing.

Frequently Asked Questions

Q.When is VolitionRx's Q3 2026 earnings conference call?

VolitionRx scheduled its conference call to discuss third-quarter 2026 financial and operational results for Friday, November 13, 2026, at 8:30 a.m. U.S. Eastern Time.

Q.What stock exchange is VolitionRx listed on?

VolitionRx Limited trades on NYSE American under the ticker symbol VNRX.

Q.What does VolitionRx do as a company?

VolitionRx is a multinational epigenetics company headquartered in Henderson, Nevada, focused on the science of heritable changes in gene expression without alterations to DNA sequences.

More in markets →